Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prescription After Cesarean Trial

NCT04296396 is registered in ClinicalTrials.gov with The George Washington University Biostatistics Center as lead sponsor.

NCT NCT04296396
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04296396 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prescription After Cesarean Trial
Lead sponsor
The George Washington University Biostatistics Center
Phase
Phase 3
Overall status
Completed
Start date
September 21, 2020
Completion date
July 8, 2022
Enrollment
5,521 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use, pain, pregnancy related